Opportunity Information: Apply for PA 09 020
Apply for PA 09 020
- The National Institutes of Health in the education health sector is offering a public funding opportunity titled "International Research Collaboration on Drug Abuse and Addiction Research (R01)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279 Drug Abuse and Addiction Research Programs.
- This funding opportunity was created on Oct 29, 2008 and posted on Oct 29, 2008.
- Applicants must submit their applications by Jan 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification) Public housing authorities/Indian housing authorities Private institutions of higher education Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Native American tribal organizations (other than Federally recognized tribal governments) Public and State controlled institutions of higher education Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) State governments County governments City or township governments Small businesses.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The International Research Collaboration on Drug Abuse and Addiction Research (R01) opportunity (Funding Opportunity Number PA 09 020) is a National Institutes of Health program announcement designed to support research projects that involve meaningful collaboration outside the United States. The main idea is to fund drug abuse and addiction studies that become stronger, faster, or more scientifically valuable because part of the work is done internationally, where researchers can access distinctive advantages that are difficult or impossible to replicate domestically. Those advantages might include specialized scientific expertise, unique facilities or resources, specific patient or community populations, or environmental and social conditions that create rare research settings. Projects must align with the mission of the National Institute on Drug Abuse (NIDA) and, when feasible, should also connect to NIDA scientific priority areas, which are updated over time. For the FY09 period mentioned in the announcement, examples of priority topics included connections between drug abuse and HIV/AIDS, methamphetamine abuse, inhalant abuse, smoking during pregnancy, and drug-impaired driving.
This funding announcement uses the NIH Research Project Grant (R01) mechanism, which typically supports more mature, hypothesis-driven research programs with a defined scope and a stronger evidence base than smaller exploratory mechanisms. The announcement also notes that it runs in parallel with companion funding opportunities of the same scientific scope that use different grant types: an R21 for exploratory/developmental projects and an R03 for small research grants. In practice, that means the scientific goals can be similar across these three announcements, but applicants choose the mechanism that best matches the maturity, scale, and budget needs of their proposed work, with the R01 generally being the most substantial of the three.
Funding decisions under PA 09 020 depend on two practical constraints: the availability of appropriated funds and the presence of a sufficient number of high-quality, fundable applications. The announcement does not promise a fixed number of awards; instead, it signals that awards will be made when meritorious proposals are received and funding permits. There is no cost sharing or matching requirement, which simplifies budgeting because applicants are not required to contribute non-federal funds as a condition of receiving the award.
Eligibility is broad and includes many types of organizations that commonly apply for NIH grants. Eligible applicants include public and private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status, aside from institutions of higher education), for-profit organizations (other than small businesses), small businesses, and multiple levels of government (state, county, city or township, special district governments, and independent school districts). The announcement also explicitly includes a wide range of mission-focused and community-based institutions such as Historically Black Colleges and Universities (HBCUs), Hispanic-Serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, and tribal entities (including federally recognized tribal governments and other tribal organizations). Importantly for an international collaboration program, non-U.S. entities (foreign organizations) and regional organizations are also listed as eligible, as are U.S. territories or possessions and eligible federal agencies.
Key administrative details place the announcement within the federal grants system as a discretionary grant in the Education/Health activity category, under CFDA number 93.279 (Drug Abuse and Addiction Research Programs). The posting and creation date is October 29, 2008, and the original and final closing date listed is January 7, 2012, with an archive date of February 7, 2012, meaning this specific announcement is no longer active but remains relevant as a reference point for how NIH/NIDA structured international collaboration opportunities at that time. The full announcement was hosted on the NIH grants site, and NIH Office of Extramural Research (OER) support contact information was provided for applicants who had trouble accessing or linking to the electronic posting.
FAQs: International Research Collaboration on Drug Abuse and Addiction Research (R01) - PA 09 020
What is the PA 09 020 funding opportunity?
PA 09 020 is an NIH Program Announcement for the International Research Collaboration on Drug Abuse and Addiction Research using the NIH Research Project Grant (R01) mechanism. It is designed to support drug abuse and addiction research projects that involve meaningful collaboration outside the United States.
What is the main purpose of this opportunity?
The purpose is to fund drug abuse and addiction studies that are strengthened by doing part of the research internationally. The international component should provide distinctive advantages that would be difficult or impossible to replicate within the United States.
What kinds of "distinctive advantages" does NIH expect from the international collaboration?
The announcement highlights advantages such as access to specialized scientific expertise, unique facilities or resources, specific patient or community populations, and environmental or social conditions that create rare research settings.
Does the project have to be conducted entirely outside the United States?
No. The announcement emphasizes that part of the work is done internationally and that the international collaboration is meaningful and adds scientific value. It does not state that the entire project must occur outside the United States.
Which NIH institute mission should the project align with?
Projects must align with the mission of the National Institute on Drug Abuse (NIDA).
Are there specific scientific priorities mentioned?
Yes. The announcement notes that, when feasible, projects should connect to NIDA scientific priority areas, which are updated over time. For the FY09 period referenced, examples included links between drug abuse and HIV/AIDS, methamphetamine abuse, inhalant abuse, smoking during pregnancy, and drug-impaired driving.
What grant mechanism does PA 09 020 use?
This announcement uses the NIH Research Project Grant (R01) mechanism, which typically supports more mature, hypothesis-driven research programs with a defined scope and stronger evidence base compared with smaller exploratory mechanisms.
Are there related opportunities with the same scientific scope?
Yes. The announcement notes companion funding opportunities with the same scientific scope but different grant mechanisms: an R21 (exploratory/developmental) and an R03 (small research grant). Applicants select the mechanism that matches the maturity, scale, and budget needs of their project, with the R01 generally being the most substantial.
How are funding decisions made under this announcement?
Funding depends on two constraints: (1) availability of appropriated funds and (2) receipt of a sufficient number of high-quality, fundable applications. The announcement does not promise a fixed number of awards.
Is there a guaranteed number of awards?
No. The announcement indicates awards will be made when meritorious proposals are received and funding permits, rather than committing to a set number of awards.
Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement, meaning applicants are not required to contribute non-federal funds as a condition of award.
Who is eligible to apply?
Eligibility is broad and includes public and private institutions of higher education; nonprofit organizations (with or without 501(c)(3) status, other than institutions of higher education); for-profit organizations (other than small businesses); small businesses; and multiple levels of government (state, county, city or township, special district governments, and independent school districts).
Are community-based and mission-focused institutions eligible?
Yes. The announcement explicitly includes organizations such as HBCUs, Hispanic-Serving Institutions, Tribal Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, and tribal entities (including federally recognized tribal governments and other tribal organizations).
Are non-U.S. (foreign) organizations eligible?
Yes. Non-U.S. entities (foreign organizations) and regional organizations are listed as eligible applicants, which fits the international collaboration purpose of the program.
Are U.S. territories and federal agencies eligible?
Yes. The announcement lists U.S. territories or possessions as eligible, and it also includes eligible federal agencies.
What type of federal award is this?
The opportunity is described as a discretionary grant within the Education/Health activity category.
What is the CFDA number associated with this program?
The CFDA number listed is 93.279, titled Drug Abuse and Addiction Research Programs.
When was PA 09 020 posted?
The posting and creation date provided is October 29, 2008.
What were the closing and archive dates?
The original and final closing date listed is January 7, 2012, and the archive date is February 7, 2012.
Is this announcement still active?
No. Based on the final closing and archive dates provided, this specific announcement is no longer active. It remains useful as a reference for how NIH/NIDA structured international collaboration opportunities during that period.
Where was the full announcement hosted?
The full announcement was hosted on the NIH grants site.
Who could applicants contact for technical issues accessing the posting?
The announcement indicates that NIH Office of Extramural Research (OER) support contact information was provided for applicants who had trouble accessing or linking to the electronic posting.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education Health
Next opportunity: International Research Collaboration on Drug Abuse and Addiction Research (R21)
Previous opportunity: Medical Management of Older Patients with HIV/AIDS (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 020
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 020) also looked into and applied for these:
| Funding Opportunity |
|---|
| International Research Collaboration on Drug Abuse and Addiction Research (R21) Apply for PA 09 021 Funding Number: PA 09 021 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| International Research Collaboration on Drug Abuse and Addiction Research (R03) Apply for PA 09 022 Funding Number: PA 09 022 Agency: National Institutes of Health Category: Education Health Funding Amount: $50,000 |
| Central Nervous System Intersections of Drug Addiction, Chronic Pain and Analgesia (R21) Apply for RFA DA 09 018 Funding Number: RFA DA 09 018 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Secondary Data Analyses for Substance Abuse Research (R21/R33) Apply for RFA DA 09 020 Funding Number: RFA DA 09 020 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Brain Imaging Studies of Negative Reinforcement in Humans (R01) Apply for RFA DA 09 008 Funding Number: RFA DA 09 008 Agency: National Institutes of Health Category: Education Health Funding Amount: $250,000 |
| Brain Imaging Studies of Negative Reinforcement in Humans (R21) Apply for RFA DA 09 009 Funding Number: RFA DA 09 009 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Instrument Development for Biomedical Applications (R21) Apply for RFA RR 09 001 Funding Number: RFA RR 09 001 Agency: National Institutes of Health Category: Education Health Funding Amount: $125,000 |
| Erythropoiesis Stimulating Agents and Tumor Progression (R01) Apply for PA 09 023 Funding Number: PA 09 023 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Erythropoiesis Stimulating Agents and Tumor Progression (R21) Apply for PA 09 024 Funding Number: PA 09 024 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| National Cancer Institute Program Project (P01) Applications Apply for PAR 09 025 Funding Number: PAR 09 025 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Collaborative Research in Integrative Cancer Biology and the Tumor Microenvironment (U01) Apply for PAR 09 026 Funding Number: PAR 09 026 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Education Programs of Excellence in Scientifically Validated Behavioral Treatment (R25) Apply for RFA MH 09 110 Funding Number: RFA MH 09 110 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Shared Instrumentation Grant Program (S10) Apply for PAR 09 028 Funding Number: PAR 09 028 Agency: National Institutes of Health Category: Education Health Funding Amount: $500,000 |
| Mutant Mouse Regional Resource Centers (Limited Competition U42) Apply for RFA RR 09 003 Funding Number: RFA RR 09 003 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Mutant Mouse Regional Resource Centers (U42) Apply for RFA RR 09 002 Funding Number: RFA RR 09 002 Agency: National Institutes of Health Category: Education Health Funding Amount: $750,000 |
| STUDIES OF ENERGY BALANCE AND CANCER IN HUMANS Apply for PA 04 124 Funding Number: PA 04 124 Agency: National Institutes of Health Category: Education Health Funding Amount: $200,000 |
| Ruth L. Kirschstein National Research Service Award (NRSA) for Individual Predoctoral Fellows (F31) in Nursing Research Apply for PAR 05 091 Funding Number: PAR 05 091 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| IDeA Networks of Biomedical Research Excellence (INBRE) P20 Apply for PAR 08 150 Funding Number: PAR 08 150 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Quantitative Imaging for Evaluation of Responses to Cancer Therapies (U01) Apply for PAR 08 225 Funding Number: PAR 08 225 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
| Specialized Programs of Research Excellence (SPOREs) in Human Cancer for the Year 2008 and 2009 (P50) Apply for PAR 08 020 Funding Number: PAR 08 020 Agency: National Institutes of Health Category: Education Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 020", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.